Advertisement
International
Subscribe to International

The Lead

Judge Halts Alzheimer's Drug Swap Until July

December 16, 2014 8:47 am | by MICHAEL VIRTANEN, Associated Press | News | Comments

U.S. District Judge Robert Sweet told Dublin-based Actavis PLC to continue making the drug Namenda available for 30 days after generic alternatives become available on July 11 "in order to allow for an orderly transition."     

France Wants to Legalize Terminal Sedation

December 15, 2014 8:57 am | by SYLVIE CORBET, Associated Press | News | Comments

France's president wants to allow doctors to keep terminally ill patients sedated until death...

Swiss Researchers Suspend Ebola Vaccine Trial

December 11, 2014 10:05 am | by The Associated Press | News | Comments

Swiss researchers have suspended the testing of one of the leading Ebola vaccine candidates...

Paralegal Says Sanofi Fired Her for Whistleblowing

December 8, 2014 8:41 am | by LINDA A. JOHNSON, AP Business Writer | News | Comments

A paralegal recently fired by French drugmaker Sanofi has filed a whistleblower lawsuit,...

View Sample

FREE Email Newsletter

Charges Dropped Against Two Former Lilly Scientists

December 8, 2014 8:34 am | News | Comments

Two former Eli Lilly and Co. employees who were accused of sending trade secrets worth more than $55 million to a competing Chinese drug company will no longer face charges, the U.S. attorney's office announced Friday.      

Meda to End Penicillin Contract with Recipharm; Layoffs Forecast

December 4, 2014 1:44 pm | News | Comments

Meda, a Recipharm’s customer, announced that they will transfer supply of their mainly Swedish penicillin products and manufacture offshore with other suppliers. The manufacturing contract with Recipharm Strängnäs will therefore be terminated as of December 31, 2015.

Catalent and Sellas to Collaborate on Therapeutic Reprofiling of Zolpidem

December 4, 2014 10:00 am | News | Comments

Catalent Pharma Solutions has reached an exclusive development and licensing agreement with Swiss-based development-stage biopharmaceutical company SELLAS Life Sciences Group, to support the development and therapeutic reprofiling of zolpidem using Catalent’s OSDrC® OptiDose™ drug delivery technology.

Advertisement

GlobalData: Age-Related Macular Degeneration Treatment Market Value to Exceed $10B by 2023

December 4, 2014 9:51 am | News | Comments

The Age-related Macular Degeneration treatment market across seven major countries (the US, UK, Germany, France, Spain, Italy and Japan) will almost double in value from $5.1 billion in 2013 to $10.1 billion by 2023, according to research and consulting firm GlobalData.

EMA: Novartis Flu Vaccine OK

December 3, 2014 1:30 pm | News | Comments

Europe's drug regulator says there is no proof that a flu vaccine for the elderly was linked to side effects, including deaths in Italy. Last week, Italy pulled two batches of Fluad, made by Switzerland's Novartis AG, after reports that people died after getting immunized.

Evotec and Sanofi Form Major Multi-Component Strategic Collaboration

December 2, 2014 1:52 pm | News | Comments

Evotec AG has entered into exclusive negotiations with Sanofi on a major multi-component strategic alliance over the next five years. The collaboration will comprise three major strategic initiatives all focused on improving innovation effectiveness in the drug discovery and pre-clinical development space.

Johnson Matthey Acquires Pharmaceutical Manufacturing Capacity in Scotland, UK

December 2, 2014 11:43 am | News | Comments

Johnson Matthey, a provider of pharmaceutical services, APIs and catalyst technologies, has announced completion of an acquisition of pharmaceutical manufacturing capacity in Scotland, U.K. The 109,000 sq. meter site was acquired to meet increasing demand for custom pharmaceutical services and active ingredients utilising enhanced manufacturing capabilities.

Otsuka to Buy Avanir for $3.5B

December 2, 2014 7:08 am | by By The Associated Press | News | Comments

Otsuka Pharmaceutical will spend $3.5 billion in cash to buy Avanir Pharmaceuticals in a deal that expands the Japanese drugmaker's portfolio of neurologic disease treatments. Avanir shareholders will receive $17 per share, according to the agreement announced Tuesday.

Advertisement

Italy's Ebola Patient Gets Experimental Treatment

November 25, 2014 11:35 am | News | Comments

An Italian doctor who contracted Ebola while working in Sierra Leone has arrived back in Italy and is being treated with the same experimental drugs used in the U.S. and other European countries to treat people infected with the virus.   

EMA: No Consistent Evidence of an Increased Risk of Heart Problems with Testosterone Medicines

November 21, 2014 8:13 am | News | Comments

The CMDh, a regulatory body representing EU Member States, has agreed by consensus that there is no consistent evidence of an increased risk of heart problems with testosterone medicines in men who lack the hormone (a condition known as hypogonadism).

German Court: e-Cigarette Liquids Not Medicines

November 20, 2014 3:32 pm | News | Comments

A German federal court has ruled that the liquids contained in e-cigarettes aren't medicinal products and can be sold freely.                     

Vetter Opens Singapore Office to Support Growing Asian Healthcare Market

November 20, 2014 8:42 am | News | Comments

Vetter has announced the opening of a new representative office in Singapore. The announcement was made at a ceremony attended by members of local government agencies and a number of executives of pharmaceutical/biotech companies with a presence in the Asian region, as well as Vetter executives.

British, Dutch Kill Poultry to Fight Bird Flu

November 18, 2014 8:43 am | by GREGORY KATZ, Associated Press | News | Comments

Chickens were being killed in the Netherlands, and Britain was preparing to kill ducks, after two cases of bird flu were discovered in Europe — but officials insisted Monday that the risk to public health was very low.      

Advertisement

Heart Stents May Require Longer Blood Thinner Use

November 18, 2014 8:37 am | by MARILYNN MARCHIONE, AP Chief Medical Writer | News | Comments

Millions of people with stents that prop open clogged heart arteries may need anti-clotting drugs much longer than the one year doctors recommend now. A large study found that continuing for another 18 months lowers the risk of heart attacks, clots and other problems.

China Convicts Pharmaceutical Web Marketer in Anti-Rumor Campaign

November 18, 2014 8:06 am | News | Comments

A Beijing court has convicted an Internet marketer of illegal business practices and sentenced him to four years in prison for posting false information and deleting posts critical of his clients, in a case that state media have used to praise a government crackdown on online expression.

BMS to Construct a New Large-Scale Biologics Manufacturing Facility in Cruiserath, Ireland

November 17, 2014 8:31 am | News | Comments

Bristol-Myers Squibb Company has announced plans to construct a new state-of-the-art, large-scale biologics manufacturing facility in Cruiserath, County Dublin, Ireland, that will produce multiple therapies for the company’s growing biologics portfolio.

Drug Maker Arrested in India Sterilization Deaths

November 17, 2014 8:25 am | by MUNEEZA NAQVI, Associated Press | News | Comments

Press Trust of India reported that Ramesh Mahawar of Mahawar Pharma Pvt Ltd and his son were arrested and charged with fraud. Police Superintendent O.P. Pal told PTI that the men were arrested on the complaint of food and drug administration officials.

India Doctor Arrested, Denies Role in Women Deaths, Blames Medication

November 13, 2014 10:07 am | by MUNEEZA NAQVI, Associated Press | News | Comments

The doctor who conducted sterilization procedures after which 13 women died in central India was arrested, but insisted he didn't do anything wrong — even though he said he used to perform up to 10 times more surgeries a day than allowed.    

Doctors Rush to India after Sterilization Deaths

November 12, 2014 8:30 am | by KATY DAIGLE, Associated Press | News | Comments

A team of doctors rushed to central India on Wednesday after at least 12 women died and dozens of others fell ill following sterilization surgeries in a free, nationwide program aimed at limiting births in the world's second-most populous nation, officials said.

Orexigen Rises as Weight Loss Drug Review Proceeds

November 10, 2014 2:24 pm | News | Comments

Shares of Orexigen Therapeutics jumped Monday after the company said a European Union review of its weight loss drug Contrave, which was approved in the U.S. in September, is progressing on schedule.         

China Factory Whirs Overtime to Make Ebola Suits

November 6, 2014 10:56 am | by ZHANG WEIQUN, Associated Press | News | Comments

Far from the Ebola hot zone, the sewing and gluing machines at a factory in China have been whirring more than usual to produce crucial yellow suits that protect the front-line medics more than 11,000 kilometers (7,000 miles) away in West Africa.

Beijing Wants APEC to Push Chinese Trade Pact

November 6, 2014 8:19 am | by JOE McDONALD, AP Business Writer | News | Comments

China plans to use a meeting of Asia-Pacific leaders to promote a regional trade initiative at a time when progress on a rival U.S.-led trade deal has stalled, injecting a note of rivalry into an annual summit that aims for consensus.   

GVK BIO to Acquire Vanta Bioscience

November 6, 2014 8:16 am | News | Comments

GVK BIO has announced the signing of a definitive agreement to acquire Vanta Bioscience, a full service preclinical GLP toxicology and safety assessment contract research organization operating out of Chennai, India.      

Ex-Union Carbide Chief Anderson Dies at 92

November 2, 2014 6:29 pm | by CURT ANDERSON, Associated Press | News | Comments

Warren M. Anderson, who headed Union Carbide Corp. when a chemical leak killed thousands of people in Bhopal, India, in 1984, has died in Florida at 92. Anderson's death was not announced by his family but was confirmed Friday by The Associated Press through public records.

New Bill in Japan Would Extend Sales Suspension of Quasi-Legal Drugs

November 2, 2014 5:28 pm | News | Comments

The ruling Liberal Democratic Party and its coalition partner have drawn up a draft amendment to the pharmaceutical affairs law that would extend the suspension of sales of quasi-legal drugs nationwide when a retailer is ordered to suspend sales of such drugs.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading